These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3588517)

  • 1. Neuroleptic malignant syndrome during perphenazine treatment.
    Nielsen D; Aunsholt NA; Andersen PT
    Pharmacol Toxicol; 1987 Mar; 60(3):221-2. PubMed ID: 3588517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome presenting without fever: case report and review of the literature.
    Lev R; Clark RF
    J Emerg Med; 1994; 12(1):49-55. PubMed ID: 8163805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of neuroleptic malignant syndrome with acute renal failure after the discontinuation of sulpiride and maprotiline.
    Kiyatake I; Yamaji K; Shirato I; Kubota M; Nakayama S; Tomino Y; Koide H
    Jpn J Med; 1991; 30(4):387-91. PubMed ID: 1942657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoglobinuric acute renal failure in phencyclidine overdose: report of observations in eight cases.
    Patel R; Das M; Palazzolo M; Ansari A; Balasubramaniam S
    Ann Emerg Med; 1980 Nov; 9(11):549-53. PubMed ID: 7436062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in the multiple trauma patient.
    Quinn DE; Goodman MA
    J Orthop Trauma; 1989; 3(1):68-70. PubMed ID: 2709208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic therapy following neuroleptic malignant syndrome.
    Pelonero AL; Levenson JL; Silverman JJ
    Psychosomatics; 1985 Dec; 26(12):946-7. PubMed ID: 4089133
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa.
    Lambrecht ER; Meems BJ
    Neth J Med; 1987 Feb; 30(1-2):80-4. PubMed ID: 3587463
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure.
    Sanai T; Matsui R; Hirano T; Torichigai S; Yotsueda H; Higashi H; Hirakata H; Iida M
    Ren Fail; 2006; 28(1):51-5. PubMed ID: 16526319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome during perphenazine treatment in a patient with head and neck cancer: a case report.
    Zohar Y; Talmi YP; Sabo R; Finkelstein Y; Korzets A
    Otolaryngol Head Neck Surg; 1992 Feb; 106(2):206-8. PubMed ID: 1738556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome presenting with acute renal failure.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1074-5. PubMed ID: 18281139
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome.
    Lenhard T; Külkens S; Schwab S
    Arch Neurol; 2007 Jan; 64(1):122-5. PubMed ID: 17210819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure in neuroleptic malignant syndrome.
    Nishioka Y; Miyazaki M; Kubo S; Ozono Y; Harada T; Kohno S
    Ren Fail; 2002 Jul; 24(4):539-43. PubMed ID: 12212835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoglobinuric renal failure due to drug-induced rhabdomyolysis.
    Hampel G; Horstkotte H; Rumpf KW
    Hum Toxicol; 1983 Apr; 2(2):197-203. PubMed ID: 6862462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity.
    Van Praag HM; Korf J; Dols LC
    Br J Psychiatry; 1976 Dec; 129():547-55. PubMed ID: 1000139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perphenazine enanthate. Results of a 1-year open multicenter study].
    Baruch P; Brion S; Broussolle P; Gayral LF; Ropert R; Volmat R; Porot M
    Encephale; 1989; 15(5):449-55. PubMed ID: 2686965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of neuroleptic malignant syndrome associated with myoglobinuric acute renal failure].
    Oochi N; Sanai T; Kobayashi K; Nanishi F; Nunoi K; Onoyama K; Fujishima M
    Nihon Naika Gakkai Zasshi; 1987 Aug; 76(8):1264-8. PubMed ID: 2890700
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-response relationships of perphenazine in the treatment of acute psychoses.
    Hansen LB; Larsen NE; Gulmann N
    Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.